<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362285">
  <stage>Registered</stage>
  <submitdate>22/03/2012</submitdate>
  <approvaldate>22/03/2012</approvaldate>
  <actrnumber>ACTRN12612000334808</actrnumber>
  <trial_identification>
    <studytitle>The Swinburne Multivitamin Study: The Effects of Multivitamin Supplementation on mood, stress and brain function in older adults</studytitle>
    <scientifictitle>An investigation of multivitamin supplementation on measures of mood, stress and brain function in a healthy cohort of adults aged over 50 years</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Influence of nutrients on mood and stress in healthy older adults</healthcondition>
    <healthcondition>Investigate the role of cardiovascular system in relation to mood and stress</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Other alternative and complementary medicine</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Normal development and function of the cardiovascular system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The current study compares multivitamin supplementation to a placebo.  Participants are instructed to take one tablet daily with food, for a period of 16 weeks.  

Swisse Women's Ulitivite 50+ V
One tablet per day for 16 weeks.
RETINYL ACETATE (equiv. to 2500 IU of vitamin A) 862.5 mcg
d-ALPHA-TOCOPHERYL ACID SUCCINATE (equiv. vitamin E 24.2 IU) 20 mg
THIAMINE HYDROCHLORIDE (vitamin B1) 30 mg
RIBOFLAVINE (vitamin B2) 30 mg
NICOTINAMIDE (vitamin B3) 20 mg
CALCIUM PANTOTHENATE (vitamin B5) (equiv. pantothenic acid 64.13mg) 70 mg
PYRIDOXINE HYDROCHLORIDE (vitamin B6) (equiv. pyridoxine 24.68mg) 30 mg
CYANOCOBALAMIN (vitamin B12) 115 mcg 
CHOLECALCIFEROL (vitamin D3) (equiv. vitamin D 200 IU) 5mcg
BIOTIN (vitamin H) 150 mcg
FOLIC ACID 500 mcg
CALCIUM ASCORBATE DIHYDRATE (vitamin C)(equiv. ascorbic acid 165.3mg) 200 mg
PHYTOMENADIONE (vitamin K1) 60 mcg
CITRUS BIOFLAVONOIDS EXTRACT 20 mg
CALCIUM OROTATE (equiv. calcium 10mg) 100 mg
MAGNESIUM ASPARTATE DIHYDRATE (equiv. magnesium 6.74mg) 100 mg
SELENOMETHIONINE (equiv. selenium 26mcg) 65 mcg
MOLYBDENUM TRIOXIDE (equiv. molybdenum 45mcg) 67.5 mcg
CHROMIUM PICOLINATE (equiv. chromium 50 mcg) 402 mcg
MANGANESE AMINO ACID CHELATE (equiv. manganese 3mg) 30 mg
FERROUS FUMERATE (equiv. iron 5mg) 16.01 mg
COPPER GLUCONATE (equiv. copper 1.2mg) 8.57 mg
POTASSIUM IODIDE (equiv. iodine 149.83mcg) (equiv. potassium 46.18mcg) 196 mcg
ZINC AMINO ACID CHELATE (equiv. zinc 15mg) 75 mg
Lactobacillius rhamnosus 80 million organisms 
Lactobacillus acidophilus 80 million organisms
Bifidobacterium longum 35 million organisms
VACCINIUM MACROCARPON FRUIT DRY (patented cranberry PACRAN) 800 mg
SILYBUM MARIANUM DRY FRUIT (St. Marys thistle) (equiv. flavanolignans calculated as silybin 17.14mg) 1500 mg
GINKGO BILOBA LEAF DRY (Maidenhair tree) (equiv. Ginkgo flavonglycosides 4.8mg and ginkgolides and bilobalide 1.2mg) 1000 mg
TUNERA DIFFUSA LEAF DRY (Damiana) 500 mg
SCUTELLARIA LATERIFLORA HERB DRY (Skullcap) 50 mg
VITIS VINIFERA DRY SEED (Grape seed) (equiv. procyanidins 7.9mg) 1000 mg
URTICA DIOICA LEAF DRY (Nettle) 100 mg
UBIDECARENONE (Co-enzyme Q10) (from patented Ultrasome CoQ10) 2 mg
CYNARA SCOLYMUS LEAF DRY (Globe artichoke) 50 mg
CIMICIFUGA RACEMOSA ROOT &amp; RHIZOME DRY (Black cohosh) 200 mg
CURCUMA LONGA RHIZOME DRY (Tumeric) 100 mg
WITHANIA SOMNIFERA ROOT DRY (Ashwagandha) 500 mg
CRATAEGUS MONOGYNA FRUIT DRY (Hawthorn) 100 mg
SILICA COLLOIDAL ANHYDROUS (equiv. silicon 9.35mg) 20 mg
BACOPA MONNIERI WHOLE PLANT DRY (Bacopa) (equiv. bacosides calculated as bacoside A 1.125mg) 50 mg
LECITHIN POWDER  SOY PHOSPHATIDYLSERINE ENRICHED SOY (equiv. phosphatidylserine 2mg) 10 mg
SPEARMINT OIL 2 mg
VACCINIUM MYRTILLUS FRUIT DRY (Bilberry) (equiv. anthocyanosides 324mcg) 100 mg
TAGETES ERECTA FLOWER DRY (Marigold) (Lutein esters calculated as lutein (of Tagetes erecta) 1mg) 100 mg 

Swisse Men's Ultivite 50+ V
Multivitamin, mineral and herbal supplementation.
One tablet per day for 16 weeks.
Swisse Men's Ultivite 50+ V

RETINYL ACETATE (equiv. to 2500 IU of vitamin A) 862.5 mcg
d-ALPHA-TOCOPHERYL ACID SUCCINATE (equiv. vitamin E 30.25 IU) 25 mg
THIAMINE HYDROCHLORIDE (vitamin B1) 35 mg
RIBOFLAVINE (vitamin B2) 35 mg
NICOTINAMIDE (vitamin B3) 25 mg
CALCIUM PANTOTHENATE (vitamin B5) (equiv. pantothenic acid 68.7mg) 75 mg
PYRIDOXINE HYDROCHLORIDE (vitamin B6) (equiv. pyridoxine 20.56mg) 25 mg
CYANOCOBALAMIN (vitamin B12) 120 mcg
CHOLECALCIFEROL (vitamin D3) (equiv. vitamin D 200 IU) 5mcg
BIOTIN (vitamin H) 200 mcg
FOLIC ACID 500 mcg
CALCIUM ASCORBATE DIHYDRATE (vitamin C) (equiv. ascorbic acid 165.3mg) 200 mg
PHYTOMENADIONE (vitamin K) 70 mcg
CITRUS BIOFLAVONOIDS EXTRACT 20 mg
CALCIUM OROTATE (equiv. calcium 10mg) 100 mg
MAGNESIUM ASPARTATE DIHYDRATE (equiv. magnesium 6.74mg) 100 mg
SELENOMETHIONINE (equiv. selenium 26mcg) 65 mcg
MOLYBDENUM TRIOXIDE (equiv. molybdenum 45mcg) 67.5 mcg
CHROMIUM PICOLINATE (equiv. chromium 50 mcg) 402 mcg
MANGANESE AMINO ACID CHELATE (equiv. manganese 4mg) 40 mg
FERROUS FUMERATE (equiv. iron 5mg) 16.01 mg
COPPER GLUCONATE (equiv. copper 1.7mg) 12.14 mg
POTASSIUM IODIDE (equiv. iodine 149.83mcg) (equiv. potassium 46.18mcg) 196 mcg
ZINC AMINO ACID CHELATE (equiv. zinc 20mg) 100 mg
Lactobacillius rhamnosus 80 million organisms 
Lactobacillus acidophilus 80 million organisms
Bifidobacterium longum 35 million organisms
VACCINIUM MACROCARPON FRUIT DRY (patented cranberry PACRAN) 1000 mg
SILYBUM MARIANUM DRY FRUIT (St. Marys thistle) (equiv. flavanolignans calculated as silybin 19.43mg) 1700 mg
GINKGO BILOBA LEAF DRY (Maidenhair tree) (equiv. Ginkgo flavonglycosides 4.8mg and ginkgolides and bilobalide 1.2mg) 1000 mg
TRIBULUS TERRESTRIS FRUIT &amp; ROOT DRY (Tribulus) 1000 mg
DULACIA INOPIFLORA ROOT DRY (Muirapuama) 200 mg
SCUTELLARIA LATERIFLORA HERB DRY (Skullcap) 50 mg
VITIS VINIFERA DRY SEED (Grape seed) (equiv. procyanidins 7.9mg) 1000 mg
SERENOA REPENS FRUIT DRY (Saw palmetto) (equiv. fatty acids 27mg) 300 mg
URTICA DIOICA LEAF DRY (Nettle) 50 mg
UBIDECARENONE (Co-enzyme Q10) (from patented Ultrasome CoQ10) 3 mg
CYNARA SCOLYMUS LEAF DRY (Globe artichoke) 50 mg
CRATAEGUS MONOGYNA FRUIT DRY (Hawthorn) 120 mg
LECITHIN POWDER  SOY PHOSPHATIDYLSERINE ENRICHED SOY (equiv. phosphatidylserine 2mg) 10 mg
SPEARMINT OIL 2 mg
VACCINIUM MYRTILLUS FRUIT DRY (Bilberry) (equiv. anthocyanosides 324mcg) 100 mg
TAGETES ERECTA FLOWER DRY (Marigold) (Lutein esters calculated as lutein (of Tagetes erecta) 1mg) 100 mg</interventions>
    <comparator>Placebo:One tablet per day for 16 weeks. Women's:One tablet per day for 16 weeks. EXCIPIENTS: CELLULOSE-MICROCRYSTALLINE CROSPOVIDONE CROSCARMELLOSE SODIUM POVIDONE MAGNESIUM STEARATE COATING: HYPROMELLOSE CACROGOL 400 TITANIUM DIOXIDE IRON OXIDE RED IRON OXIDE YELLOW SPEARMINT OIL CARNAUBA WAX Men's:One tablet per day for 16 weeks. EXCIPIENTS: CELLULOSE-MICROCRYSTALLINE CROSPOVIDONE CROSCARMELLOSE SODIUM POVIDONE SILICON DIOXIDE MAGNESIUM STEARATE COATING: CHLOROPHYLLIN COPPER COMPLEX OPADRY II WHITE SPEARMINT OIL CARNAUBA WAX</comparator>
    <control>Placebo</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Scores on mood and stress scales.  These scales include:
-Beck Depression Inventory (BDI)
-Beck Anxiety Inventory (BAI)
-The Depression, Anxiety, Stress Scale (DASS)
-The Perceived Stress Scale (PSS)
-The Hospital Depression and Anxiety Scale (HADS)</outcome>
      <timepoint>Before and after 16 weeks of supplementation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>patterns of brain electrical activity using the steady state visual evoked potential technique</outcome>
      <timepoint>Before and after 16 weeks of supplementation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Stress/mood using multitasking battery to induce stress and mood questionnaires before and after stress task.  The questionnaires include
-Bond Lader Visual Analogue Scales
-The State/Trait anxiety Index (STAI)
-The NASA-task load index (After task only)</outcome>
      <timepoint>Before and after 16 weeks of supplementation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Blood levels of: homocysteine; c-reactive protein; fibrinogen; lipids; vitamins B6, B12, E, zinc and folate; electrolytes; telomere length.</outcome>
      <timepoint>Before and after 16 weeks of supplementation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cardiovascular function using transcranial doppler ultrasound and arterial stiffness measure (using sphygmocor system)</outcome>
      <timepoint>Before and after 16 weeks of supplementation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-Right-handed
-free from psychiatric disorders
-Must not be taking anticoagulants, antidepressants, antipsychotics, anxiolytics, acetylcholine esterase (AChE) inhibitors, anti-Parkinsons medication, illicit drugs or any cognitive enhancing drugs
-must not be taking any vitamin/mineral or herbal supplements
-non-smoker</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-smokers
-psychiatric disorders
-using vitamins/minerals or herbal supplements
-taking anticoagulants, antidepressants, antipsychotics, anxiolytics, acetylcholine esterase (AChE) inhibitors, anti-Parkinsons medication, illicit drugs or any cognitive enhancing drugs
-left-handed</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants will be recruited via newspaper advertisements as well as through our internal clinical trials database. Participants are randomly assigned to numbered containers which the sponsor randomly allocated to one of the treatment conditions. The individual who screened participants and conducted testing was not involved or aware of the allocation of supplements.</concealment>
    <sequence>Permuted block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>None</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>19/09/2009</anticipatedstartdate>
    <actualstartdate>12/05/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>25/06/2012</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize>84</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Swinburne University</primarysponsorname>
    <primarysponsoraddress>Street and Postal Address:
Centre for Human Psychopharmacology,
Swinburne Univeristy of Technology,
427-457 Burwood Road,
Hawthorn, VIC, 3122</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Swisse Vitamins Pty Ltd</fundingname>
      <fundingaddress>Street and Postal Address:
36-38 Gipps Street,
Collingwood, Victoria, 3066.</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The use of complementary and alternative medicines is on the rise, with many people opting to supplement their diet in order to top-up nutrients lacking from their diet.  Recently, research has associated poor nutrition with cognitive decline, and it has also been suggested that aspects of nutrient intake may be associated with mood.  Research has found associations between depressive symptoms and a number of key micronutrients, however little research has investigated the role of multivitamin supplementation on symptoms of anxiety and stress.  This study will investigate the effect of supplementation with 50+ Ultivite on mood, stress and brain function in healthy, community-dwelling, older participants.   Specifically, the study will aim to investigate the role of supplementation on measures of depression, anxiety and stress, as well as measures of brain function.</summary>
    <trialwebsite />
    <publication>NA</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Swinburne University Human Research Ethics Committee (SUHREC)</ethicname>
      <ethicaddress>Research ethics officer
Swinburne research (H68)
Swinburne University of Technology
PO Box 218
Hawthorn Vic, 3122</ethicaddress>
      <ethicapprovaldate>8/04/2009</ethicapprovaldate>
      <hrec>SUHREC Project 2008/147 The effect of multivitamin supplementation on mood, stress and brain electrical activity</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Dr. Andrew Pipingas</name>
      <address>Centre for Human Psychopharmacology
Swinburne Univeristy of Technology,
427-457 Burwood Road,
Hawthorn, VIC, 3122, Australia.</address>
      <phone>+61 3 9214 5215</phone>
      <fax />
      <email>apipingas@swin.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Renee Rowsell</name>
      <address>Centre for Human Psychopharmacology
Swinburne Univeristy of Technology,
427-457 Burwood Road,
Hawthorn, VIC, 3122, Australia.</address>
      <phone>+61 3 9214 5656</phone>
      <fax />
      <email>rrowsell@swin.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Andrew Pipingas</name>
      <address>Centre for Human Psychopharmacology
Swinburne Univeristy of Technology,
427-457 Burwood Road,
Hawthorn, VIC, 3122, Australia.</address>
      <phone>+61 3 9214 5215</phone>
      <fax />
      <email>apipingas@swin.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Andrew Pipingas</name>
      <address>Centre for Human Psychopharmacology Swinburne Univeristy of Technology, 427-457 Burwood Road, Hawthorn, VIC, 3122, Australia</address>
      <phone>+61 3 9214 5215</phone>
      <fax />
      <email>apipingas@swin.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>